Literature DB >> 9659257

ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.

R A Still1, I F McDowell.   

Abstract

Plasma homocysteine is emerging as an important risk factor for cardiovascular disease. Measurement in clinical laboratories is feasible by several techniques, including HPLC. Of particular importance is the potential for treatment by dietary modification and vitamin supplements, particularly folic acid. The outcome of vitamin intervention on cardiovascular events is awaited with interest. If the role of homocysteine is confirmed then it may rival cholesterol in importance as a cardiovascular risk factor.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9659257      PMCID： PMC500636          DOI： 10.1136/jcp.51.3.183

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  26 in total

1.  The effect of blood sample aging and food consumption on plasma total homocysteine levels.

Authors:  J B Ubbink; W J Vermaak; A van der Merwe; P J Becker
Journal:  Clin Chim Acta       Date:  1992-04-30       Impact factor: 3.786

2.  Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum.

Authors:  J B Ubbink; W J Hayward Vermaak; S Bissbort
Journal:  J Chromatogr       Date:  1991-04-19

3.  Validation of abbreviated oral methionine-loading test.

Authors:  A G Bostom; R Roubenoff; P Dellaripa; M R Nadeau; P Sutherland; P W Wilson; P F Jacques; J Selhub; I H Rosenberg
Journal:  Clin Chem       Date:  1995-06       Impact factor: 8.327

Review 4.  Total homocysteine in plasma or serum: methods and clinical applications.

Authors:  P M Ueland; H Refsum; S P Stabler; M R Malinow; A Andersson; R H Allen
Journal:  Clin Chem       Date:  1993-09       Impact factor: 8.327

Review 5.  Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis.

Authors:  M M Rees; G M Rodgers
Journal:  Thromb Res       Date:  1993-09-01       Impact factor: 3.944

6.  Homocysteine species as components of plasma redox thiol status.

Authors:  P M Ueland
Journal:  Clin Chem       Date:  1995-03       Impact factor: 8.327

7.  Homocysteine and other thiols in plasma and urine: automated determination and sample stability.

Authors:  T Fiskerstrand; H Refsum; G Kvalheim; P M Ueland
Journal:  Clin Chem       Date:  1993-02       Impact factor: 8.327

8.  Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.

Authors:  A B Guttormsen; J Schneede; T Fiskerstrand; P M Ueland; H M Refsum
Journal:  J Nutr       Date:  1994-10       Impact factor: 4.798

9.  Homocysteine and myocardial infarction.

Authors:  B Israelsson; L E Brattström; B L Hultberg
Journal:  Atherosclerosis       Date:  1988-06       Impact factor: 5.162

10.  Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency.

Authors:  S P Stabler; J Lindenbaum; D G Savage; R H Allen
Journal:  Blood       Date:  1993-06-15       Impact factor: 22.113
View more
  8 in total

1.  Homocysteine and cardiovascular disease.

Authors:  A F Winder
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

Review 2.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.

Authors:  David Mischoulon; Jonathan E Alpert; Erland Arning; Teodoro Bottiglieri; Maurizio Fava; George I Papakostas
Journal:  J Clin Psychiatry       Date:  2012-05-15       Impact factor: 4.384

4.  Effect of methionine loading on pulse wave analysis in elderly volunteers.

Authors:  S R Hart; A A Mangoni; C G Swift; S H D Jackson
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

5.  A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.

Authors:  Timothy R Morgan; Kathryn Osann; Teodoro Bottiglieri; Neville Pimstone; John C Hoefs; Ke-Qin Hu; Tarek Hassanein; Thomas D Boyer; Lorene Kong; Wen-Pin Chen; Ellen Richmond; Rachel Gonzalez; Luz M Rodriguez; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-30

6.  The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients.

Authors:  Sibel Ertek; Ayse Nur Torun; Kenan Ates
Journal:  Int Urol Nephrol       Date:  2009-08-04       Impact factor: 2.370

7.  Hyperhomocysteinemia and cardiovascular disease: The nutritional perspectives.

Authors:  R Pandey; S Gupta; H Lal; H C Mehta; S K Aggarwal
Journal:  Indian J Clin Biochem       Date:  2000-08

8.  Hyperhomocysteinemia: An emerging risk factor for cardiovascular disease.

Authors:  V Govindaraju; C N Manjunath; H Venkataramiah; T R Raghu
Journal:  Indian J Clin Biochem       Date:  2003-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.